Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bioxyne financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-28
Market Capitalization
$26.6 M
2024-10-28
Revenue
$28.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0M | 2.1M | 2.3M | 2.1M | 2.4M | 5.2M | 9.4M | 28.4M |
| Cost of goods sold | 1.1M | 990.0K | 1.0M | 992.0K | 1.1M | 3.2M | 5.8M | 18.1M |
| Gross profit | 1.1M | 1.2M | 1.3M | 1.2M | 1.4M | 2.2M | 4.0M | 11.2M |
| Gross profit margin, % | 55.1% | 56.9% | 57.1% | 57.4% | 58.2% | 41.7% | 42.2% | 39.3% |
| Operating expense total | 2.5M | 2.6M | 1.7M | 1.4M | 1.5M | 4.0M | 5.4M | 5.8M |
| Depreciation and amortization | 284.0K | 87.0K | 50.0K | 206.0K | 11.8M | 461.0K | ||
| EBITDA | (1.4M) | (1.4M) | (367.0K) | (168.0K) | (89.0K) | (1.8M) | (1.4M) | 5.3M |
| EBITDA margin, % | -71.3% | -65.8% | -16.2% | -8.0% | -3.7% | -34.8% | -15.2% | 18.8% |
| EBIT | (1.4M) | (1.4M) | (651.0K) | (255.0K) | (139.0K) | (2.0M) | (13.3M) | 4.9M |
| EBIT margin, % | -71.3% | -65.8% | -28.8% | -12.1% | -5.8% | -38.8% | -141.6% | 17.2% |
| Interest income | 38.0K | 41.0K | 40.0K | 19.0K | 15.0K | 3.0K | 17.0K | 22.0K |
| Interest expense | 7.0K | 2.0K | 1.0K | |||||
| Pre tax profit | (1.3M) | (1.3M) | (593.0K) | (496.0K) | (237.0K) | (2.0M) | (13.5M) | 4.9M |
| Net Income | (1.3M) | (1.3M) | (593.0K) | (496.0K) | (237.0K) | (2.0M) | (13.5M) | 4.9M |